www.dechra-us.com.
Dechra Veterinary Products, located in Overland Park, Kansas, is the U.S. sales and marketing division of Dechra Pharmaceuticals Limited. Our expertise is in the development, manufacture, and sales and marketing of high-quality products exclusively for veterinarians worldwide. We are driven by our purpose of sustainable improvement of local animal health and welfare.
Dechra’s equine portfolio is diverse and focuses on mobility, joint health, reproduction, anesthesia/analgesia, dermatology, ophthalmology, and fluid therapy.
Our key brands include Zycosan® (pentosan polysulfate sodium injection), Osphos® (clodronate injection), ProVet APC® (Autologous Platelet Concentrate) system, SucroMate® Equine (deslorelin acetate), and Equidone® (domperidone) Gel and Vetivex® IV Fluids.
Dechra’s rapid growth is fueled by these key products and others in the portfolio, as well as recent highly successful acquisitions, including Putney (2016), Piedmont (2022), and Med-Pharmex (2022). We continue to grow because we understand the challenges veterinarians face and we give them what they need. Dechra provides continual training and support to help veterinarians help animals. Why not check out further recourses for veterinarians: https://go.dechra-us.com/equine-resources
